SEE2CURE
See2cure is addressing abdominal metastases with an intraoperative platform that combines detection and treatment. The company’s tumour-targeting protein technology enables real-time fluorescence imaging to reveal hidden cancer cells during surgery, while also delivering drugs directly to residual disease. The platform
Based, SEE2CURE works in health.
Profile
See2cure is addressing abdominal metastases with an intraoperative platform that combines detection and treatment. The company’s tumour-targeting protein technology enables real-time fluorescence imaging to reveal hidden cancer cells during surgery, while also delivering drugs directly to residual disease. The platform targets the Thomsen-Friedenreich (TF) antigen (CD176), a universal biomarker found in around 80% of solid […]
Within the health space, the company focuses on its core offering rather than a broad product line.
It is recorded at the Creative Destruction Lab alumni company stage.
| Sector | Health |
|---|---|
| Stage | Creative Destruction Lab alumni company |
Website: www.see2cure.com
Browse related
Create a free account